Browse by Publication

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2016 | 2014 | 2013 | 2011 | 2005 | 2004 | 2002 | 2001
Number of items: 11.

2016

Martin, NK; Vickerman, P; Dore, GJ; Grebely, J; Miners, A; Cairns, J; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Martin, TC; +3 more... (2016) How should HCV treatment be prioritized in the direct-acting antiviral era? An economic evaluation including population prevention benefits. Journal of hepatology, 65 (1). pp. 17-25. ISSN 0168-8278 DOI: 10.1016/j.jhep.2016.02.007 Full text not available from this repository.

2014

Tan, AT; Hoang, LT; Chin, D; Rasmussen, E; Lopatin, U; Hart, S; Bitter, H; Chu, T; Gruenbaum, L; Ravindran, P; +8 more... (2014) Reduction of HBV replication prolongs the early immunological response to IFNα therapy. Journal of hepatology, 60 (1). pp. 54-61. ISSN 0168-8278 DOI: 10.1016/j.jhep.2013.08.020 Full text not available from this repository.

2013

Martin, NK; Hickman, M; Miners, A; Hutchinson, SJ; Taylor, A; Vickerman, P; (2013) COST-EFFECTIVENESS OF INCREASING HCV CASE-FINDING FOR PEOPLE WHO INJECT DRUGS VIA DRIED BLOOD SPOT TESTING IN ADDICTION SERVICES AND PRISONS. [Conference or Workshop Item] Full text not available from this repository.

Martin, NK; Vickerman, P; Clements, A; Cramp, M; de Angeles, D; Dillon, JF; Fahey, S; Foster, GR; Goldberg, DJ; Gordon, F; +7 more... (2013) ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS. [Conference or Workshop Item] Full text not available from this repository.

Shimakawa, Y; Lemoine, M; Njai, HF; Jatta, A; Sanneh, B; Taal, M; Corrah, T; D'Alessandro, U; Njie, R; Thursz, M; (2013) COMMUNITY-BASED SCREENING FOR HEPATITIS B VIRUS INFECTION IN THE GAMBIA, WEST AFRICA: PREVALENCE OF INFECTION AND FACTORS AFFECTING THE SCREENING ATTENDANCE. [Conference or Workshop Item] Full text not available from this repository.

2011

Martin, NK; Vickerman, P; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Hickman, M; (2011) Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of hepatology, 54 (6). pp. 1137-44. ISSN 0168-8278 DOI: 10.1016/j.jhep.2010.08.029 Full text not available from this repository.

Thursz, M; Corradini, SG; Toniutto, P; Molinaro, A; Palla, L; Knapp, S; Anstee, Q; Huang-Doran, I; Goldin, R; Romeo, S; (2011) PNPLA3 SEQUENCE VARIANT (RS738409) CONFERS SUSCEPTIBILITY TO LIVER DAMAGE AND CIRRHOSIS IN HCV RELATED LIVER DISEASE. [Conference or Workshop Item] Full text not available from this repository.

2005

Khan, S; Mandeville, K; Toledano, M; Thomas, H; Taylor-Robinson, S; (2005) Update of mortality and incidence rates for intrahepatic cholangiocarcinoma and other hepatobiliary tumours in England & Wales. Journal of hepatology (42 Suppl 2). ISSN 0168-8278 Full text not available from this repository.

2004

Lluch, P; Torondel, B; Medina, P; Segarra, G; Del Olmo, JA; Serra, MA; Rodrigo, JM; (2004) Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. Journal of hepatology, 41 (1). pp. 55-9. ISSN 0168-8278 DOI: 10.1016/j.jhep.2004.03.016 Full text not available from this repository.

2002

2001

Dumpis, U; Holmes, EC; Mendy, M; Hill, A; Thursz, M; Hall, A; Whittle, H; Karayiannis, P; (2001) Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. Journal of hepatology, 35 (1). pp. 99-104. ISSN 0168-8278 Full text not available from this repository.

This list was generated on Sat Apr 29 13:36:33 2017 BST.